查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598429

凝血酶市场：按类型、形式和最终用户划分 - 全球预测 2025-2030

Thrombin Market by Type (Bovine Thrombin, Human Plasma Thrombin, Recombinant Thrombin), Form (Liquid, Powder), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年凝血酶市值为6.4896亿美元，预计2024年将达到6.8505亿美元，复合年增长率为6.14%，预计到2030年将达到9.8529亿美元。

凝血酶是一种对血液凝固很重要的酶，广泛用于医疗程序中以帮助止血。对凝血酶的主要需求是由于它在控制出血方面的作用，这使得它在手术环境和伤口处理中至关重要。凝血酶的应用范围涵盖从医院到专业手术中心的各种最终用途，并且其向生物製药研究的扩展增加了一个新的维度。凝血酶市场受到成长要素的影响，例如全球外科手术的增加、心血管疾病盛行率的上升以及提高凝血酶有效性的生物技术的进步。重组凝血酶和其他生物工程版本的开发有新的机会，有望解决与传统版本相关的过敏原和病原体传播挑战。

主要市场统计
基准年[2023] 64896万美元
预测年份 [2024] 68505万美元
预测年份 [2030] 98529万美元
复合年增长率（%） 6.14%

然而，市场面临局限性，特别是高製造成本和替代混凝剂的竞争。监管障碍和严格的安全要求也带来了重大挑战，并可能减缓产品核可和市场扩张。人们也担心某些患者会出现副作用，这可能会限制更广泛的应用。儘管存在这些挑战，技术创新可以透过专注于分子修饰来提高凝血酶的生物有效性和特异性来推动业务成长。此外，开发具有长保质期和稳定配方的凝血酶类似物的研究可以开拓新的市场。

凝血酶市场的动态本质反映了成熟应用和新技术进步的融合。重组DNA技术提供了更安全、更可控的凝血酶变体，是一个有前景的业务发展领域。为了抓住市场机会，企业应投资与生技公司和研究机构建立策略伙伴关係，以推动符合监管标准的共同创新。透过了解这些细微差别，公司可以更好地驾驭市场格局，并透过结合创新研究和策略远见，他们可以有效地应对挑战，同时释放自己的潜力。

市场动态：揭示快速发展的凝血酶市场的关键市场洞察

供需的动态交互作用正在改变凝血酶市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 外科手术的数量和止血剂的需求增加
    • 扩大凝血酶作为肉类黏合剂的用途
  • 市场限制因素
    • 凝血酶的复杂製造过程
  • 市场机会
    • 扩大药物开发活动以促进凝血酶的使用
    • 凝血酶功能的进展
  • 市场挑战
    • 凝血酶过度使用的主要健康风险

波特的五力：驾驭凝血酶市场的策略工具

波特的五力架构是了解凝血酶市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解凝血酶市场的外部影响

外部宏观环境因素在塑造凝血酶市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解凝血酶市场的竞争状况

对凝血酶市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵凝血酶市场供应商的绩效评估

FPNV定位矩阵是评估凝血酶市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製凝血酶市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，凝血酶市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 外科手术和止血剂需求的增加
      • 扩大凝血酶作为肉类粘合剂的用途
    • 抑制因素
      • 凝血酶的生产过程复杂
    • 机会
      • 扩大药物开发活动以促进凝血酶的使用
      • 凝血酶功能的演化
    • 任务
      • 过度使用凝血酶会带来严重的健康风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章凝血酶市场：依类型

  • 牛凝血酶
  • 人类血浆凝血酶
  • 重组凝血酶

第七章凝血酶市场：依形式

  • 液体
  • 粉末

第 8 章凝血酶市场：依最终使用者分类

  • 医院/诊所
  • 医学研究/学术机构

第9章美洲凝血酶市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太凝血酶市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲凝血酶市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Baxter International Inc.
  • Bayer AG
  • BIOFAC A/S
  • BioMedica Diagnostics Inc.
  • BioPharm Laboratories, LLC
  • Cayman Chemical
  • DiaPharma Group, Inc.
  • Grifols, SA
  • Johnson & Johnson Services, Inc.
  • Medix Biochemica USA Inc.
  • Merck KGaA
  • Mochida Pharmaceutical Co., Ltd.
  • MyBioSource
  • Octapharma AG
  • Pfizer, Inc.
  • Prolytix
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Regen Lab SA
  • Rocky Mountain Biologicals, LLC.
  • Shanghai RAAS blood products co., Ltd
  • Takeda Pharmaceutical Company Limited.
  • Teleflex Incorporated.
  • Thermo Fisher Scientific Inc.
  • XD BIOCHEMS LIMITED
Product Code: MRR-C002B1C99628

The Thrombin Market was valued at USD 648.96 million in 2023, expected to reach USD 685.05 million in 2024, and is projected to grow at a CAGR of 6.14%, to USD 985.29 million by 2030.

Thrombin, a crucial enzyme for blood coagulation, is extensively utilized in medical procedures to aid in hemostasis. Its primary necessity stems from its role in controlling bleeding, making it indispensable in surgical settings and wound management. The application scope for thrombin spans across various end-uses, from hospitals to specialized surgical centers, and its deployment in biopharmaceutical research adds another dimension. The market for thrombin is influenced by growth factors such as an increase in surgical procedures globally, the rising prevalence of cardiovascular diseases, and advancements in biotechnology that enhance thrombin's efficacy. Emerging opportunities lie in the development of recombinant thrombin and other bioengineered variants, which promise to address allergens and pathogen-transmission challenges associated with traditional forms.

KEY MARKET STATISTICS
Base Year [2023] USD 648.96 million
Estimated Year [2024] USD 685.05 million
Forecast Year [2030] USD 985.29 million
CAGR (%) 6.14%

However, the market faces limitations, notably the high cost of thrombin production and competition from alternative clotting agents. Regulatory hurdles and stringent safety requirements also pose significant challenges, potentially delaying product approvals and market expansion. There are also concerns about adverse reactions in a subset of patients that can limit its broader application. Despite these challenges, innovation can drive business growth by focusing on molecular modifications to enhance thrombin bioavailability and specificity. Moreover, research into developing thrombin analogs with longer shelf life and stable formulations could open new markets.

The dynamic nature of the thrombin market reflects a blend of matured applications and nascent technological advancements. Recombinant DNA technology represents a promising area for business development, providing a safer and more controlled thrombin variant. To capitalize on market opportunities, businesses should invest in strategic partnerships with biotechnology firms and research institutions, promoting collaborative innovation that aligns with regulatory standards. By understanding these nuances, businesses can better navigate the thrombin market landscape, combining innovative research with strategic foresight to tap into its vast potential while mitigating challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Thrombin Market

The Thrombin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of surgical procedures and need for thrombin hemostatic agents
    • Expanding utilization of thrombin as a binding agent for meats
  • Market Restraints
    • Complex production process of thrombin
  • Market Opportunities
    • Expanding drug development activities promoting the usage of thrombin
    • Advancements in the functionalities of thrombin
  • Market Challenges
    • Major health risks associated with excessive usage of thrombin

Porter's Five Forces: A Strategic Tool for Navigating the Thrombin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Thrombin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Thrombin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Thrombin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Thrombin Market

A detailed market share analysis in the Thrombin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Thrombin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Thrombin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Thrombin Market

A strategic analysis of the Thrombin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Thrombin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc., Bayer AG, BIOFAC A/S, BioMedica Diagnostics Inc., BioPharm Laboratories, LLC, Cayman Chemical, DiaPharma Group, Inc., Grifols, S.A., Johnson & Johnson Services, Inc., Medix Biochemica USA Inc., Merck KGaA, Mochida Pharmaceutical Co., Ltd., MyBioSource, Octapharma AG, Pfizer, Inc., Prolytix, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Regen Lab SA, Rocky Mountain Biologicals, LLC., Shanghai RAAS blood products co., Ltd, Takeda Pharmaceutical Company Limited., Teleflex Incorporated., Thermo Fisher Scientific Inc., and XD BIOCHEMS LIMITED.

Market Segmentation & Coverage

This research report categorizes the Thrombin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bovine Thrombin, Human Plasma Thrombin, and Recombinant Thrombin.
  • Based on Form, market is studied across Liquid and Powder.
  • Based on End-User, market is studied across Hospitals & Clinics and Medical Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of surgical procedures and need for thrombin hemostatic agents
      • 5.1.1.2. Expanding utilization of thrombin as a binding agent for meats
    • 5.1.2. Restraints
      • 5.1.2.1. Complex production process of thrombin
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding drug development activities promoting the usage of thrombin
      • 5.1.3.2. Advancements in the functionalities of thrombin
    • 5.1.4. Challenges
      • 5.1.4.1. Major health risks associated with excessive usage of thrombin
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Thrombin Market, by Type

  • 6.1. Introduction
  • 6.2. Bovine Thrombin
  • 6.3. Human Plasma Thrombin
  • 6.4. Recombinant Thrombin

7. Thrombin Market, by Form

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder

8. Thrombin Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Medical Research & Academic Institutes

9. Americas Thrombin Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Thrombin Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Thrombin Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Baxter International Inc.
  • 3. Bayer AG
  • 4. BIOFAC A/S
  • 5. BioMedica Diagnostics Inc.
  • 6. BioPharm Laboratories, LLC
  • 7. Cayman Chemical
  • 8. DiaPharma Group, Inc.
  • 9. Grifols, S.A.
  • 10. Johnson & Johnson Services, Inc.
  • 11. Medix Biochemica USA Inc.
  • 12. Merck KGaA
  • 13. Mochida Pharmaceutical Co., Ltd.
  • 14. MyBioSource
  • 15. Octapharma AG
  • 16. Pfizer, Inc.
  • 17. Prolytix
  • 18. Prospec-Tany Technogene Ltd.
  • 19. Proteintech Group, Inc.
  • 20. Regen Lab SA
  • 21. Rocky Mountain Biologicals, LLC.
  • 22. Shanghai RAAS blood products co., Ltd
  • 23. Takeda Pharmaceutical Company Limited.
  • 24. Teleflex Incorporated.
  • 25. Thermo Fisher Scientific Inc.
  • 26. XD BIOCHEMS LIMITED

LIST OF FIGURES

  • FIGURE 1. THROMBIN MARKET RESEARCH PROCESS
  • FIGURE 2. THROMBIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL THROMBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL THROMBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL THROMBIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL THROMBIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL THROMBIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL THROMBIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. THROMBIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. THROMBIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. THROMBIN MARKET DYNAMICS
  • TABLE 7. GLOBAL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL THROMBIN MARKET SIZE, BY HUMAN PLASMA THROMBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL THROMBIN MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL THROMBIN MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL THROMBIN MARKET SIZE, BY MEDICAL RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. THROMBIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2023